Developer docs
API playgroundTry for free, no card

Search company profiles

Valeris

Full company profile

uuid0005v4p

Namestring
Valeris
Legal namestring
Valeris Incorporated
Websiteurl
valeris.com
Company typeenum
Private
Founded yearint
2025
Descriptiontext

Valeris is a privately held life sciences commercialization platform headquartered in Morrisville, North Carolina, formed in May 2025 through the merger of Mercalis and PharmaCord. The company provides integrated end-to-end commercialization services to pharmaceutical and biotechnology manufacturers, operating across three service pillars: Insights and Data (strategy consulting and market access intelligence), Patient Support Services (access and affordability programs, non-commercial dispensing pharmacy, nursing support, patient engagement and adherence, eServices curation, and virtual clinical trial supply), and Healthcare Provider Engagement (contract sales teams, field reimbursement support, medical science liaisons, clinical nurse educators, and institutional sales support). Valeris also maintains two wholly-owned subsidiaries, Policy Reporter and Triangle Insights Group, which contribute market access data intelligence and consulting capabilities, respectively.

The platform is anchored by four proprietary technology products: Policy Reporter (described as the industry's leading source of market access policy and coverage data, including a first-in-market Medical Benefit Maximizer module), Valeris Vantage (an operational intelligence platform combining real-time guidance and data insights for patient support teams), the Valeris eServices Curator (a centralized contract service for acquiring eServices), and RxStudy Card (a virtual clinical trial supply solution). These products sit atop a digital patient engagement platform with web and iOS/Android mobile applications featuring behavior-based messaging, habit tracking, and symptom management. The company holds ISO 27001 certification for protected health information security management.

Valeris generates revenue primarily through professional services fees paid by life sciences brands under custom, quote-based B2B enterprise contracts negotiated for each commercialization engagement. The company reports serving 500+ life sciences partners, supporting 44M+ patients, and generating $34B+ in patient savings across its programs, with 10,000+ in-home nursing visits delivered through its field network. Valeris maintains 1,001–5,000 employees and operates exclusively in the United States, targeting pharmaceutical manufacturers seeking integrated commercialization partners across the product lifecycle.

Short descriptiontext

Valeris is a privately held US life sciences commercialization platform serving 500+ pharmaceutical and biotech manufacturers with integrated patient support, market access intelligence, and healthcare provider engagement services backed by proprietary technology including Policy Reporter and Valeris Vantage.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersMorrisville, United States
HQ citystring
Morrisville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical commercialization services, patient support services, market access intelligence, healthcare provider engagement, life sciences consulting
Industry4 codes
PRIMARYHLAIAKAI
Channel & Trade Strategy (Gross-to-Net, Distribution Economics)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLALABAL
Virtual Pharmacy & Medication Management Integration Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
NAICS code2 codes
  • Management Consulting Services54161
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code2 codes
  • Services-Management Consulting Services8742
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Commercialization Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Commercialization Services
TypeProfessional Services
Description

Integrated life sciences and pharmaceutical commercialization services including strategy consulting, market access intelligence, patient support services, and healthcare provider engagement. Revenue generated through service fees for these commercial partnership arrangements with pharmaceutical brands.

valeris.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Policy Reporter
Description

Industry's leading source of market access policy and coverage data that integrates with Valeris patient support services programs, empowering agents and healthcare provider engagement teams to deliver fast, accurate information.

valeris.com
+3 more records
Core offering1 text field

Valeris delivers integrated life sciences and pharmaceutical commercialization services spanning insights and data, patient support services, and healthcare provider engagement. Its offerings combine strategy consulting, market access intelligence (via Policy Reporter™), patient access and affordability programs, non-commercial dispensing pharmacy, nursing support, digital patient engagement, virtual clinical trial supply (RxStudy Card™), eServices acquisition, and HCP-facing field teams such as contract sales, field reimbursement, medical science liaisons, clinical nurse educators, and institutional sales support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • $34B+ in patient savings across 44M+ patients supported with 500+ life sciences partners
+1 more record
Product overview1 text field

Valeris is an integrated life sciences commercialization partner offering a platform-plus-services architecture combining proprietary technology products with comprehensive service offerings. The core technology products include Valeris Vantage™ (operational intelligence platform), Policy Reporter™ (market access intelligence), RxStudy Card™ (virtual clinical trial supply), and Valeris eServices Curator (eServices procurement). These are supported by three main service pillars: Insights and Data (Strategy Consulting, Market Access Intelligence), Patient Support Services (Patient Access and Affordability, Non-Commercial Dispensing Pharmacy, Nursing Support, Patient Engagement and Adherence), and Healthcare Provider Engagement (Contract Sales, Field Reimbursement, Medical Science Liaisons, Clinical Nurse Educators, Institutional Sales Support). The company was formed in May 2025 through the merger of Mercalis and PharmaCord.

Product and service13 records
1End-to-End Commercialization Partnership
CategoryCommercialization Services
Description

Integrated life sciences and pharmaceutical commercialization partnership offering a seamless experience across insights, strategy, data, and solutions for pharmaceutical and biotech brands across the product lifecycle.

2Strategy Consulting
CategoryInsights and Data
Description

Guidance from experienced life sciences advisors to help pharmaceutical and biotech clients navigate complex product, prescription, and patient journeys with tailored solutions.

3Market Access Intelligence
CategoryInsights and Data
Description

On-demand access to Policy Reporter for market access policy and coverage data, integrated with Valeris patient support services programs to deliver fast, accurate information to patients and providers.

4Patient Access and Affordability
CategoryPatient Support Services
Description

Solutions for access and affordability integrated into patient support services programs, aligning financial assistance needs of patients with strategic business expectations of life science brands.

5Non-Commercial Dispensing Pharmacy
CategoryPatient Support Services
Description

Dispenses consigned products as free goods to patients in need, supporting QuickStart and Bridge programs and electronic prescription transmission from EMR systems.

6Nursing Support Services
CategoryPatient Support Services
Description

Multiple channels for clinical education and patient support including onsite and in-house nurse educators providing product and disease education combined with adherence and psychosocial support.

7Patient Engagement and Adherence
CategoryPatient Support Services
Description

End-to-end digital platform delivering patient support for specialty drug programs and clinical trials through text message alerts, copay enrollment, and ongoing adherence reminders.

8RxStudy Card™ Virtual Clinical Trial Supply
CategoryPatient Support Services
Description

Virtual clinical trial supply solution offering a more efficient and reliable way to procure commercially available clinical trial supplies, minimizing cost, time, and waste compared to traditional bulk procurement.

9Contract Sales Team
CategoryHealthcare Provider Engagement
Description

Scalable and strategic outreach services to generate leads, educate, and engage healthcare providers across the value chain on behalf of life sciences clients.

10Field Reimbursement Support
CategoryHealthcare Provider Engagement
Description

Reimbursement manager services supporting clinical trials and assisting healthcare providers with coverage and reimbursement processes.

11Medical Science Liaisons
CategoryHealthcare Provider Engagement
Description

Expert liaison services connecting life sciences companies with healthcare providers through scientific communication and support.

12Clinical Nurse Educators
CategoryHealthcare Provider Engagement
Description

Healthcare provider engagement strategies utilizing clinical nurse educators for product education and provider support.

13Institutional Sales Support
CategoryHealthcare Provider Engagement
Description

Virtual HCP engagement services supporting institutional sales efforts and provider relationships.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

Mercalis and PharmaCord finalized a merger in May 2025 to form Valeris, creating a large integrated commercialization partner focused on coordinated patient support services in the US healthcare market. This merger combined complementary capabilities to establish Valeris as a major player in the pharma hub and patient access support service sector.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

PharmaCord merged with Mercalis in May 2025 to form Valeris, creating a large integrated commercialization partner focused on coordinated patient support services in the US healthcare market. This merger combined complementary capabilities to establish Valeris as a major player in the pharma hub and patient access support service sector.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Eversana is an integrated life sciences commercialization services provider offering patient services, market access, HCP engagement, and consulting — a directly comparable full-stack commercialization platform to Valeris.

TypeBroad incumbent
Description

IQVIA is the largest life sciences services conglomerate spanning R&D, real-world data, market access, and commercial/contract sales — overlapping with Valeris in market access intelligence and patient/HCP engagement as part of a much broader portfolio.

TypeDirect peer
Description

Inizio (formed from Ashfield and other agencies) provides commercialization, medical affairs, and patient engagement services to pharma — directly comparable to Valeris's HCP engagement and patient support service pillars.

TypeDirect peer
Description

Syneos Health offers clinical and commercial services including contract sales, patient solutions, and medical affairs — competing head-to-head with Valeris's HCP engagement and patient support offerings for pharma brand teams.

TypeDirect peer
Description

ConnectiveRx specializes in patient access, affordability, and adherence programs for pharma — closely overlapping with Valeris's patient support services and RxStudy Card clinical trial supply capabilities.

TypeDirect peer
Description

OptimizeRx provides market access and affordability messaging through EHR workflows — comparable to Valeris's Policy Reporter market access intelligence and digital patient engagement platform offerings.

TypeBroad incumbent
Description

Cencora is a top-tier pharmaceutical distributor with significant commercialization and patient services operations — a broader incumbent that overlaps with Valeris in specialty distribution and patient support adjacencies.

TypeBroad incumbent
Description

Cardinal Health is a major pharmaceutical distributor and healthcare services operator with related patient and provider services — overlapping with Valeris's non-commercial dispensing pharmacy and patient access functions.

9McKesson
TypeBroad incumbent
Description

McKesson is a leading pharmaceutical distributor and biopharma services provider with US Bioservices and CoverMyMeds — comparable to Valeris in patient access, affordability, and HCP-facing services at much larger scale.

TypeEmerging player
Description

Claritas Rx focuses on patient support program technology and specialty pharmacy analytics — an emerging niche player with partial overlap to Valeris's digital patient engagement and patient access offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Valeris

Pharmaceutical Commercialization Servicesvaleris.com

Valeris is a privately held US life sciences commercialization platform serving 500+ pharmaceutical and biotech manufacturers with integrated patient support, market access intelligence, and healthcare provider engagement services backed by proprietary technology including Policy Reporter and Valeris Vantage.

What Valeris does

Valeris is a privately held life sciences commercialization platform headquartered in Morrisville, North Carolina, formed in May 2025 through the merger of Mercalis and PharmaCord. The company provides integrated end-to-end commercialization services to pharmaceutical and biotechnology manufacturers, operating across three service pillars: Insights and Data (strategy consulting and market access intelligence), Patient Support Services (access and affordability programs, non-commercial dispensing pharmacy, nursing support, patient engagement and adherence, eServices curation, and virtual clinical trial supply), and Healthcare Provider Engagement (contract sales teams, field reimbursement support, medical science liaisons, clinical nurse educators, and institutional sales support). Valeris also maintains two wholly-owned subsidiaries, Policy Reporter and Triangle Insights Group, which contribute market access data intelligence and consulting capabilities, respectively.

The platform is anchored by four proprietary technology products: Policy Reporter (described as the industry's leading source of market access policy and coverage data, including a first-in-market Medical Benefit Maximizer module), Valeris Vantage (an operational intelligence platform combining real-time guidance and data insights for patient support teams), the Valeris eServices Curator (a centralized contract service for acquiring eServices), and RxStudy Card (a virtual clinical trial supply solution). These products sit atop a digital patient engagement platform with web and iOS/Android mobile applications featuring behavior-based messaging, habit tracking, and symptom management. The company holds ISO 27001 certification for protected health information security management.

Valeris generates revenue primarily through professional services fees paid by life sciences brands under custom, quote-based B2B enterprise contracts negotiated for each commercialization engagement. The company reports serving 500+ life sciences partners, supporting 44M+ patients, and generating $34B+ in patient savings across its programs, with 10,000+ in-home nursing visits delivered through its field network. Valeris maintains 1,001–5,000 employees and operates exclusively in the United States, targeting pharmaceutical manufacturers seeking integrated commercialization partners across the product lifecycle.

Valeris firmographics

Firmographics
Name
Valeris
Legal name
Valeris Incorporated
Website
https://valeris.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Valeris is a privately held US life sciences commercialization platform serving 500+ pharmaceutical and biotech manufacturers with integrated patient support, market access intelligence, and healthcare provider engagement services backed by proprietary technology including Policy Reporter and Valeris Vantage.
Ownership category
akta.pro rank

Valeris industry classification

Industry
Product category
Pharmaceutical Commercialization Services
NAICS
Management Consulting Services (54161), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Services-Management Consulting Services (8742), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAKAI
Channel & Trade Strategy (Gross-to-Net, Distribution Economics)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLALABAL
Virtual Pharmacy & Medication Management Integration Platforms
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)

Keywords

  • Pharmaceutical commercialization services
  • Patient support services
  • Market access intelligence
  • Healthcare provider engagement
  • Life sciences consulting

Where Valeris is headquartered

Location

Headquarters

HQ city
Morrisville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Valeris business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Commercialization Services: Integrated life sciences and pharmaceutical commercialization services including strategy consulting, market access intelligence, patient support services, and healthcare provider engagement. Revenue generated through service fees for these commercial partnership arrangements with pharmaceutical brands.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Valeris product offering

Product offering

Core offering

Valeris delivers integrated life sciences and pharmaceutical commercialization services spanning insights and data, patient support services, and healthcare provider engagement. Its offerings combine strategy consulting, market access intelligence (via Policy Reporter™), patient access and affordability programs, non-commercial dispensing pharmacy, nursing support, digital patient engagement, virtual clinical trial supply (RxStudy Card™), eServices acquisition, and HCP-facing field teams such as contract sales, field reimbursement, medical science liaisons, clinical nurse educators, and institutional sales support.

Product overview

Valeris is an integrated life sciences commercialization partner offering a platform-plus-services architecture combining proprietary technology products with comprehensive service offerings. The core technology products include Valeris Vantage™ (operational intelligence platform), Policy Reporter™ (market access intelligence), RxStudy Card™ (virtual clinical trial supply), and Valeris eServices Curator (eServices procurement). These are supported by three main service pillars: Insights and Data (Strategy Consulting, Market Access Intelligence), Patient Support Services (Patient Access and Affordability, Non-Commercial Dispensing Pharmacy, Nursing Support, Patient Engagement and Adherence), and Healthcare Provider Engagement (Contract Sales, Field Reimbursement, Medical Science Liaisons, Clinical Nurse Educators, Institutional Sales Support). The company was formed in May 2025 through the merger of Mercalis and PharmaCord.

Differentiator

Problem solved

Functional benefit

Brands

  • Policy Reporter: Industry's leading source of market access policy and coverage data that integrates with Valeris patient support services programs, empowering agents and healthcare provider engagement teams to deliver fast, accurate information.
  • Valeris Vantage
  • RxStudy Card
  • Valeris eServices Curator

Products and services

  • End-to-End Commercialization Partnership Integrated life sciences and pharmaceutical commercialization partnership offering a seamless experience across insights, strategy, data, and solutions for pharmaceutical and biotech brands across the product lifecycle.
  • Strategy Consulting Guidance from experienced life sciences advisors to help pharmaceutical and biotech clients navigate complex product, prescription, and patient journeys with tailored solutions.
  • Market Access Intelligence On-demand access to Policy Reporter for market access policy and coverage data, integrated with Valeris patient support services programs to deliver fast, accurate information to patients and providers.
  • Patient Access and Affordability Solutions for access and affordability integrated into patient support services programs, aligning financial assistance needs of patients with strategic business expectations of life science brands.
  • Non-Commercial Dispensing Pharmacy Dispenses consigned products as free goods to patients in need, supporting QuickStart and Bridge programs and electronic prescription transmission from EMR systems.
  • Nursing Support Services Multiple channels for clinical education and patient support including onsite and in-house nurse educators providing product and disease education combined with adherence and psychosocial support.
  • Patient Engagement and Adherence End-to-end digital platform delivering patient support for specialty drug programs and clinical trials through text message alerts, copay enrollment, and ongoing adherence reminders.
  • RxStudy Card™ Virtual Clinical Trial Supply Virtual clinical trial supply solution offering a more efficient and reliable way to procure commercially available clinical trial supplies, minimizing cost, time, and waste compared to traditional bulk procurement.
  • Contract Sales Team Scalable and strategic outreach services to generate leads, educate, and engage healthcare providers across the value chain on behalf of life sciences clients.
  • Field Reimbursement Support Reimbursement manager services supporting clinical trials and assisting healthcare providers with coverage and reimbursement processes.
  • Medical Science Liaisons Expert liaison services connecting life sciences companies with healthcare providers through scientific communication and support.
  • Clinical Nurse Educators Healthcare provider engagement strategies utilizing clinical nurse educators for product education and provider support.
  • Institutional Sales Support Virtual HCP engagement services supporting institutional sales efforts and provider relationships.

Quantifiable outcome

  • $34B+ in patient savings across 44M+ patients supported with 500+ life sciences partners
  • +1 more outcomes

Companies that use Valeris

Customer profile

Segments2 records

Ideal customer profiles1 record

Valeris technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Valeris partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • MercaliscoreStrategic or Co-development Partner · 1 May 2025Mercalis and PharmaCord finalized a merger in May 2025 to form Valeris, creating a large integrated commercialization partner focused on coordinated patient support services in the US healthcare market. This merger combined complementary capabilities to establish Valeris as a major player in the pharma hub and patient access support service sector.
  • PharmaCordcoreStrategic or Co-development Partner · 1 May 2025PharmaCord merged with Mercalis in May 2025 to form Valeris, creating a large integrated commercialization partner focused on coordinated patient support services in the US healthcare market. This merger combined complementary capabilities to establish Valeris as a major player in the pharma hub and patient access support service sector.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Valeris competitors and assessment

Company assessment

Direct peers

  • Eversana: Eversana is an integrated life sciences commercialization services provider offering patient services, market access, HCP engagement, and consulting — a directly comparable full-stack commercialization platform to Valeris.
  • Inizio: Inizio (formed from Ashfield and other agencies) provides commercialization, medical affairs, and patient engagement services to pharma — directly comparable to Valeris's HCP engagement and patient support service pillars.
  • Syneos Health: Syneos Health offers clinical and commercial services including contract sales, patient solutions, and medical affairs — competing head-to-head with Valeris's HCP engagement and patient support offerings for pharma brand teams.
  • ConnectiveRx: ConnectiveRx specializes in patient access, affordability, and adherence programs for pharma — closely overlapping with Valeris's patient support services and RxStudy Card clinical trial supply capabilities.
  • OptimizeRx: OptimizeRx provides market access and affordability messaging through EHR workflows — comparable to Valeris's Policy Reporter market access intelligence and digital patient engagement platform offerings.

Broad incumbents

  • IQVIA: IQVIA is the largest life sciences services conglomerate spanning R&D, real-world data, market access, and commercial/contract sales — overlapping with Valeris in market access intelligence and patient/HCP engagement as part of a much broader portfolio.
  • Cencora (formerly AmerisourceBergen): Cencora is a top-tier pharmaceutical distributor with significant commercialization and patient services operations — a broader incumbent that overlaps with Valeris in specialty distribution and patient support adjacencies.
  • Cardinal Health: Cardinal Health is a major pharmaceutical distributor and healthcare services operator with related patient and provider services — overlapping with Valeris's non-commercial dispensing pharmacy and patient access functions.
  • McKesson: McKesson is a leading pharmaceutical distributor and biopharma services provider with US Bioservices and CoverMyMeds — comparable to Valeris in patient access, affordability, and HCP-facing services at much larger scale.

Emerging players

  • Claritas Rx: Claritas Rx focuses on patient support program technology and specialty pharmacy analytics — an emerging niche player with partial overlap to Valeris's digital patient engagement and patient access offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Valeris social profiles

Digital presence

Valeris compliance and trust

Trust signal

Compliance1 record

Valeris financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Valeris leadership team

Management profile

Number of profiles

Profiles1 record

Valeris subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Valeris funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Valeris M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Valeris

What does Valeris do?

Valeris delivers integrated life sciences and pharmaceutical commercialization services spanning insights and data, patient support services, and healthcare provider engagement. Its offerings combine strategy consulting, market access intelligence (via Policy Reporter™), patient access and affordability programs, non-commercial dispensing pharmacy, nursing support, digital patient engagement, virtual clinical trial supply (RxStudy Card™), eServices acquisition, and HCP-facing field teams such as contract sales, field reimbursement, medical science liaisons, clinical nurse educators, and institutional sales support.

Is Valeris a public or private company?

Valeris is a private company. It is classified as unknown and is currently operating.

When was Valeris founded?

Valeris was founded in 2025. It employs 501 to 1,000 people.

Where is Valeris based?

Valeris is headquartered in Morrisville, United States, in the North America region.

How does Valeris make money?

One revenue line is on record: commercialization Services.

Who are Valeris's main competitors?

Direct peers on record are Eversana, Inizio, Syneos Health, ConnectiveRx and OptimizeRx. Broad incumbents are IQVIA, Cencora (formerly AmerisourceBergen), Cardinal Health and McKesson. Claritas Rx is listed as an emerging player.

Does Valeris have an API?

No public API is recorded for Valeris.

What industry is Valeris in?

Valeris's product category is Pharmaceutical Commercialization Services. Its primary akta.pro industry code is HLAIAKAI, Channel & Trade Strategy (Gross-to-Net, Distribution Economics), with a secondary code of HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D). Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
citybizValeris Names Jeff Crowther Chief Revenue Officer to Lead Commercial GrowthValeris appointed Jeff Crowther as Chief Revenue Officer, bringing over 30 years of commercial experience. He will lead revenue strategy for services supporting 500+ life sciences customers, reporting to Scott Filosi. Crowther previously led commercial functions at Syndax and SK Life Science.PR NewswireValeris Recruits Commercial Veteran Jeff Crowther to Lead Revenue StrategyValeris appointed Jeff Crowther as Chief Revenue Officer, reporting to Chief Commercial Officer Scott Filosi. Crowther brings over 30 years of commercial leadership experience, previously serving as SVP, Commercial at Syndax Pharmaceuticals. He joins to strengthen Valeris' growth and innovation efforts.FiercePharmaPharma commercialization partner Valeris brings in new strategy chiefValeris appointed Lauren Cole as its new chief strategy officer to bolster its strategic expertise and integrate cross-functional teams. Cole joins from Verona Pharma, where she previously led patient services during the company's $10 billion acquisition by Merck. The move aims to align commercial strategy with patient access to improve outcomes for partners and patients.PR NewswireValeris Welcomes Patient Services Veteran Lauren Cole to Lead Commercial StrategyValeris appointed Lauren Cole as Chief Strategy Officer, reporting to Chief Commercial Officer Scott Filosi. Cole previously led patient services at Verona Pharma and Ardelyx, focusing on patient access and market access strategy. The appointment aims to align commercial strategy, market access, innovation, and patient services teams.PR NewswireValeris™ Names Adam Miller Chief Technology and AI Officer to Drive AI-Powered Patient AccessValeris appointed Adam Miller as Chief Technology and AI Officer, expanding the CTO role to embed AI strategy. He will lead technology with AI at the center, integrating automation and strengthening platform stability. Miller previously served as CTO at Peak Activity and vitaCare Prescription Services.MorningstarValeris Restores Full Copay Assistance Value for Client Brands After SaveOn SP Copay Maximizer RemovalValeris removed several client brands from the SaveOn SP copay maximizer drug list, restoring full manufacturer copay assistance value. The removal prevents patients' assistance from being redirected away from its intended purpose. Valeris will continue tracking plan and PBM activity affecting its client brands.PR NewswireVALERIS INTRODUCES VALERIS VANTAGE™, COMBINING REAL-TIME GUIDANCE AND DATA INSIGHTS TO HELP PATIENT SUPPORT TEAMS NAVIGATE COMPLEXITY AND IMPROVE OUTCOMESValeris, a life sciences commercialization partner headquartered in Indiana and North Carolina, announced the launch of Valeris Vantage™, a real-time Operational Intelligence Platform designed to assist patient support teams with dynamic guidance, compliance prompts, and workflow optimization during patient interactions. The platform analyzes conversations as they happen and provides next-best actions, while also serving as a workforce enablement tool for training and quality assurance. In a recent implementation with a specialty biopharmaceutical partner, the platform contributed to a 98.6% quality assurance performance score, zero patient safety errors, zero PHI-related errors, and a 65% reduction in total call errors.PR NewswireVALERIS AND FUZE HEALTH AGREE TO COLLABORATE ON ADVANCING A CONNECTED AND PERFORMANCE-DRIVEN PATIENT ACCESS MODELValeris and Fuze Health have agreed to collaborate to modernize the patient access model in life sciences by integrating digital pharmacy capabilities with access, affordability, and patient support services. The collaboration was announced at Asembia's AX26 Summit in Las Vegas and aims to create a connected, efficient, and scalable model that improves speed, coordination, and performance across the patient journey. Through this partnership, Fuze Health will lead digital pharmacy operations while Valeris will deliver comprehensive patient access services, with the goal of accelerating time to therapy and improving patient outcomes for biopharmaceutical partners.PR NewswireVALERIS TAPS INDUSTRY VETERAN SCOTT FILOSI TO LEAD COMMERCIAL STRATEGYValeris, a life sciences commercialization partner headquartered in Morrisville, North Carolina and Jeffersonville, Indiana, announced the appointment of Scott Filosi as Chief Commercial Officer effective April 7, 2026. Filosi brings nearly three decades of commercial leadership experience in the biopharmaceutical industry, having previously served as Head of US and Global Market Access, Pricing & Trade at Verona Pharma and as CEO of Luzsana Bio and Mirror Bio. The appointment is intended to strengthen Valeris's senior leadership team and accelerate growth across the company's integrated service model serving over 500 life sciences customers.